Details for New Drug Application (NDA): 050748
✉ Email this page to a colleague
The generic ingredient in SYNERCID is dalfopristin; quinupristin. Additional details are available on the dalfopristin; quinupristin profile page.
Summary for 050748
Tradename: | SYNERCID |
Applicant: | King Pharms |
Ingredient: | dalfopristin; quinupristin |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INTRAVENOUS | Strength | 350MG/VIAL;150MG/VIAL | ||||
Approval Date: | Sep 21, 1999 | TE: | RLD: | Yes |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INTRAVENOUS | Strength | 420MG/VIAL;180MG/VIAL | ||||
Approval Date: | Aug 24, 2000 | TE: | RLD: | No |
Complete Access Available with Subscription